Literature DB >> 1532593

Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation.

E M Stone1, N J Newman, N R Miller, D R Johns, M T Lott, D C Wallace.   

Abstract

Five patients with Leber's hereditary optic neuropathy (LHON) and the 11778 mitochondrial mutation spontaneously recovered 20/40 or better visual acuity in at least one eye after months to years of legal blindness. The patients ranged in age from 9 to 45 years, and the duration of visual loss before recovery ranged from several months to 5.9 years. These patients constitute only about 4% of the 136 affected LHON patients we have studied who also had the 11778 mutation in their mitochondrial DNA. Thus, even though the visual prognosis for most patients with LHON and the 11778 mutation is poor, a few individuals do recover near-normal vision in at least one eye even years after the initial visual loss.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532593

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  30 in total

1.  Coffee and doughnut maculopathy: a cause of acute central ring scotomas.

Authors:  J B Kerrison; S C Pollock; V Biousse; N J Newman
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

4.  Treatment of Leber hereditary optic neuropathy.

Authors:  Nancy J Newman
Journal:  Brain       Date:  2011-08-22       Impact factor: 13.501

5.  [LHON-Treatment option despite poor initial visual acuity?]

Authors:  A Rickmann; L Wocker; L-J Damm; C Ivanescu; P Szurman; N Pérez Guerra
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

6.  [Transorbital alternating current in optic neuropathy : December 2016. Opinion of the DOG and BVA on "Gall C et al. Alternating current stimulation for vision restoration after optic nerve damage: a randomized clinical trial. PLoS One 2016"].

Authors: 
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

7.  Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.

Authors:  Berthold Pemp; Karl Kircher; Andreas Reitner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-03       Impact factor: 3.117

Review 8.  Pathophysiology of Conversion to Symptomatic Leber Hereditary Optic Neuropathy and Therapeutic Implications: a Review.

Authors:  Alvaro J Mejia-Vergara; Nicolas Seleme; Alfredo A Sadun; Rustum Karanjia
Journal:  Curr Neurol Neurosci Rep       Date:  2020-04-15       Impact factor: 5.081

9.  Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.

Authors:  Byron L Lam; William J Feuer; Joyce C Schiffman; Vittorio Porciatti; Ruth Vandenbroucke; Potyra R Rosa; Giovanni Gregori; John Guy
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

10.  Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model.

Authors:  Mathieu Marella; Byoung Boo Seo; Biju B Thomas; Akemi Matsuno-Yagi; Takao Yagi
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.